JNJ

185.96

-1%↓

ABT

125.21

-1.57%↓

MDT

92.25

-1.86%↓

VEEV

288.4

-2.06%↓

A

145.51

-0.68%↓

JNJ

185.96

-1%↓

ABT

125.21

-1.57%↓

MDT

92.25

-1.86%↓

VEEV

288.4

-2.06%↓

A

145.51

-0.68%↓

JNJ

185.96

-1%↓

ABT

125.21

-1.57%↓

MDT

92.25

-1.86%↓

VEEV

288.4

-2.06%↓

A

145.51

-0.68%↓

JNJ

185.96

-1%↓

ABT

125.21

-1.57%↓

MDT

92.25

-1.86%↓

VEEV

288.4

-2.06%↓

A

145.51

-0.68%↓

JNJ

185.96

-1%↓

ABT

125.21

-1.57%↓

MDT

92.25

-1.86%↓

VEEV

288.4

-2.06%↓

A

145.51

-0.68%↓

Search

AstraZeneca PLC ADR

Open

83.01 0.72

Overview

Share price change

24h

Current

Min

81.76

Max

83.37

Key metrics

By Trading Economics

Income

-275M

3.1B

Sales

869M

14B

P/E

Sector Avg

31.53

37.461

Dividend yield

1.87

Profit margin

21.63

Employees

94,300

EBITDA

-87M

5B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+14.39% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.87%

2.33%

Market Stats

By TradingEconomics

Market Cap

36B

262B

Previous open

82.29

Previous close

83.01

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

AstraZeneca PLC ADR Chart

Past performance is not a reliable indicator of future results.

Related News

1 Oct 2025, 08:54 UTC

Major Market Movers

Pharma Stocks in Europe Jump After White House Unveils Drug-Buying Site

8 Sept 2025, 16:13 UTC

Major Market Movers

Dianthus Shares Whipsaw on Strong Trial Results, Safety Concerns

29 Jul 2025, 08:08 UTC

Earnings

AstraZeneca Books Record Quarterly Revenue as U.S, Oncology Boosts Growth -- Update

29 Jul 2025, 06:46 UTC

Earnings

AstraZeneca Books Record Quarterly Revenue as Oncology Boosts Growth

16 Oct 2025, 09:31 UTC

Market Talk
Earnings

AstraZeneca's Pipeline Weakness, Patent Expirations Dim Outlook -- Market Talk

13 Oct 2025, 09:33 UTC

Hot Stocks

Stocks to Watch Monday: MP Materials, AMD, Nvidia, Alibaba -- WSJ

13 Oct 2025, 08:06 UTC

Market Talk

AstraZeneca Should Face Limited Impact From Trump Pricing Deal -- Market Talk

1 Oct 2025, 09:05 UTC

Hot Stocks

Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental -- WSJ

29 Sept 2025, 09:33 UTC

Market Talk

AstraZeneca's Direct NYSE Listing May Hint at Future Intentions -- Market Talk

29 Sept 2025, 09:08 UTC

Earnings
Hot Stocks

Stocks to Watch Monday: Carnival, GSK, Alibaba -- WSJ

8 Aug 2025, 10:51 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Novartis's Midterm Prospects Look Better Than Roche's -- Market Talk

1 Aug 2025, 11:10 UTC

Hot Stocks

Global Stocks to Watch: Novo Nordisk, AXA, Daimler Truck -- WSJ

29 Jul 2025, 11:02 UTC

Earnings

AstraZeneca 2Q Adj EPS $2.17 >AZN.LN

29 Jul 2025, 11:02 UTC

Earnings

AstraZeneca 2Q EPS $1.58 >AZN.LN

29 Jul 2025, 11:01 UTC

Earnings

AstraZeneca 2Q Rev $14.5B >AZN.LN

29 Jul 2025, 11:00 UTC

Earnings

AstraZeneca Results: H1 and Q2 2025

29 Jul 2025, 08:00 UTC

Market Talk
Earnings

AstraZeneca Holding Back on a Guidance Upgrade Disappoints -- Market Talk

29 Jul 2025, 07:53 UTC

Market Talk
Earnings

AstraZeneca Continues to Deliver Under U.S. Tariff Threat -- Market Talk

29 Jul 2025, 07:26 UTC

Market Talk
Earnings

AstraZeneca Shares Look Undervalued -- Market Talk

29 Jul 2025, 06:03 UTC

Earnings

Analysts Saw AstraZeneca 2Q Total Revenue at $14.15B

29 Jul 2025, 06:03 UTC

Earnings

AstraZeneca 2Q Total Revenue $14.46B

29 Jul 2025, 06:03 UTC

Earnings

Analysts Saw AstraZeneca 2Q Core EPS at $2.16

29 Jul 2025, 06:03 UTC

Earnings

AstraZeneca 2Q Core EPS $2.17

29 Jul 2025, 06:02 UTC

Earnings

AstraZeneca Sees Core EPS Increasing by a Low Double-Digit Percentage

29 Jul 2025, 06:02 UTC

Earnings

AstraZeneca Sees Total Revenue Increasing by a High Single-Digit Percentage

29 Jul 2025, 06:02 UTC

Earnings

AstraZeneca Backs 2025 View

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Rev $14.46B

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Adj EPS $2.17

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Pretax Pft $3.13B

29 Jul 2025, 06:00 UTC

Earnings

AstraZeneca PLC 2Q Net Pft $2.45B

Peer Comparison

Price change

AstraZeneca PLC ADR Forecast

Price Target

By TipRanks

14.39% upside

12 Months Forecast

Average 94.5 USD  14.39%

High 101 USD

Low 85 USD

Based on 5 Wall Street analysts offering 12 month price targets forAstraZeneca PLC ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 69.55Support & Resistance

Short Term

Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC ADR

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat